Clinical Trial Update: UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling

View source ↗

Summary

The UCI 03-72 trial evaluating serum proteomic profiling for prostate cancer detection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of California, Irvine | Conditions: Prostate Cancer | Status: TERMINATED